Exvade Bioscience is developing breakthroughs and outside-of-the-box technologies to combat the most invasive and deadly cancers starting with Tumor Monorail technology for treating malignant brain tumors.
| Website | https://www.exvadebio.com |
| Employees | 3 (1 on RocketReach) |
| Founded | 2021 |
| Address | 380 Northyards Blvd Suite A, Atlanta, Georgia 30303, US |
| Industry | Medical Equipment Manufacturing |
| Keywords | Brain Tumor Treatment, Cancer Therapeutics, Tumor Treatment, Oncology, Cancer Research, Innovative Cancer Therapies, Immunotherapy, Drug Discovery, Pharmaceutical Research, Targeted Therapies, Precision Oncology, Biotechnology, Medical Technology, New Drug Development, Cancer Diagnostics, Molecular Medicine, Clinical Trials, Bioscience, Life Sciences |
Looking for a particular Exvade Bioscience employee's phone or email?
Sean Meehan is the Chief Operations Officer of Exvade Bioscience.
1 people are employed at Exvade Bioscience.
Exvade Bioscience is based in Atlanta, Georgia.